Table 1.
Summary of all studies.
| Outcome | ||||||
|---|---|---|---|---|---|---|
| Author/Year | Study Type, Sample Size | Country | ECMO/RRT | Mortality | ICU/Hospital LOS | ECMO Duration |
| Allyn, 2018 [28] | Cohort, 145 | France | + | + | −/− | − |
| Antonucci, 2016 [29] | Cohort, 135 | Belgium | + | + | +/− | + |
| Baek, 2016 [30] | Cohort, 12 | Korea | + | + | −/− | + |
| Chen, 2019 [31] | Cohort, 3251 | Taiwan | + | + | +/+ | + |
| Combes, 2008 [32] | Cohort, 81 | France | + | + | −/− | − |
| Dado, 2020 [33] | Cohort, 90 | USA | + | + | −/− | − |
| Deatrick, 2020 [34] | Cohort, 187 | USA | + | + | −/+ | + |
| Devasagayaraj, 2018 [35] | Cohort, 54 | USA | + | + | −/− | + |
| Elsharkawy, 2010 [36] | Cohort, 233 | USA | + | + | −/− | − |
| Fong, 2020 [37] | Cohort, 123 | HK SAR | + | + | −/− | − |
| Haneya, 2015 [38] | Cohort, 262 | Germany | + | + | −/− | − |
| He, 2018 [39] | Cohort, 32 | China | + | + | +/+ | + |
| Kielstein, 2013 [40] | Cohort, 200 | Germany | + | + | −/− | − |
| Lee SY, 2020 [41] | Cohort, 91 | Korea | + | + | −/− | − |
| Luo, 2009 [42] | Cohort, 45 | China | + | + | −/− | − |
| McCanny, 2019 [43] | Cohort, 24 | Ireland | + | + | −/− | + |
| Paek, 2018 [44] | Cohort, 296 | Korea | + | + | −/+ | − |
| Panholzer, 2017 [45]. | Cohort, 46 | Germany | + | + | −/− | − |
| Schmidt, 2014 [46] | Cohort, 172 | Australia | + | + | −/− | − |
| Thajudeen, 2015 [47] | Cohort, 40 | USA | + | + | −/− | − |
| Unosawa, 2013 [48] | Cohort, 47 | Japan | + | + | −/− | − |
| Xie, 2020 [49] | Cohort, 212 | China | + | + | −/− | − |
| Yan, 2010 [50] | Cohort, 67 | China | + | + | −/− | − |
| Yap, 2003 [51] | Case-control, 10 | Taiwan | + | + | −/− | − |
| Li, 2019 [52] | RCT, 41 | China | + | + | +/+ | + |
ECMO: extracorporeal membrane oxygenation, RRT: renal replacement therapy, ICU: intensive care unit, LOS: length of stay.